Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Rebecca C. Fitzgerald, Xiaodun Li et al.|Nature Genetics|2016Cited by 439
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesisJamie Weaver, Rebecca C. Fitzgerald, Tim Forshew et al.|Nature Genetics|2014Cited by 357
Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome DataSriganesh Jammula, Vijayendran Sujendran, Annalise Katz‐Summercorn et al.|Gastroenterology|2020Cited by 110
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinomaFergus Noble, Jamie Kelly, Megan Lloyd et al.|British journal of surgery|2017Cited by 108
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinomaSujath Abbas, Andrew Davies, Oriol Pich et al.|Nature Communications|2023Cited by 25